Deprenyl: from chemical synthesis to neuroprotection.

K. Magyar, M. Palfi, Veronica Jenei, E. Szoko

Research output: Contribution to journalArticlepeer-review

17 Citations (SciVal)


During the last decades (-)-deprenyl has become the golden standard of MAO-B inhibitors. It possesses dopamine potentiating and antioxidant properties; however, its effects cannot be explained solely by the enzyme inhibitory action. (-)-Deprenyl prevents the toxicity of certain selective neurotoxins and recently it was demonstrated to increase cell-cell adhesion as well. The complexity of its pharmacological effects reflects the action of both the parent compound and the active metabolites. (-)-Deprenyl and related propargylamines (DRPs) show neuroprotective features in a variety of in vitro and in vivo models that is dependent on the propargyl moiety. The main presumptive targets to date include glyceraldehyde-3-phosphate dehydrogenase, poly(ADP-ribose) polymerase, some kinase cascades, as well as pro- and antiapoptotic proteins, beside the inhibition of MAO-B. The antiapoptotic activity of DRPs converges upon the maintenance of mitochondrial integrity, due to the initiation of a comp
Original languageEnglish
Pages (from-to)143-156
JournalJournal of neural transmission. Supplementum
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Cancer and Oncology


Dive into the research topics of 'Deprenyl: from chemical synthesis to neuroprotection.'. Together they form a unique fingerprint.

Cite this